Have a personal or library account? Click to login
A position paper on breastfeeding by women with epilepsy – working group report Cover

A position paper on breastfeeding by women with epilepsy – working group report

Open Access
|Jun 2020

References

  1. Al-faraj A., Pang T.: Factors affecting breastfeeding patterns in women with epilepsy. Presented at: American Epilepsy Society 2019 Meeting; December 7–10; Baltimore, Maryland. Abstract 1.246. www.aesnet.org/annual_meeting/abstract_search#/
  2. American Academy of Pediatrics.: Breastfeeding and the use of human milk. Pediatrics, 2012, 3: 827–841.
  3. Amitay E.A., Keinan-Boker L.: Breastfeeding and childhood leukemia incidence. The Journal of the American Medical Association. JAMA Pediatr., 2015, 169: e151025.
  4. Anderson P.O.: Antiepileptic drugs during breastfeeding. Breastfeed Med., 2020, 15: 2–4.
  5. Atkinson H.C., Begg E.J., Darlow B.A: Drugs in human milk. Clinical pharmacokinetic considerations. Clin. Pharmacokinet., 1988, 14: 217–240.
  6. Ballard O., Morrow A.L.: Human Milk Composition. Nutrients and Bioactive Factors. Pediatr. Clin. N. Am., 2013, 60: 49–74.
  7. Belfort M.B., Rifas-Shiman S.L., Kleinman K.P., Guthrie L.B., Bellinger D.C., Taveras M.et al.: Infant feeding and childhood cognition at ages 3 and 7 years: effects of breastfeeding duration and exclusivity. JAMA Pediatr., 2013, 167: 836–844.
  8. Berlin C.M., Briggs G.G.: Drugs and chemicals in human milk. Semin. Fetal. Neonat. Med., 2005, 10: 149–159.
  9. Bernard J.Y., De Agostini M., Forhan A., Alfaiate T., Bonet M., Champion V. et al. EDEN Mother-Child Cohort Study Group: Breastfeeding duration and cognitive development at 2 and 3 years of age in the EDEN mother-child cohort. J. Pediatr., 2013, 163: 36–42.
  10. Birnbaum A.K., Meador K.J., Karanam A., Brown C., May R.C., Gerard E.E. and MONEAD Investigator Group: Antiepileptic Drug Exposure in Infants of Breastfeeding Mothers With Epilepsy. JAMA Neurol., 2019, 30: e194443. doi:10.1001/jamaneurol.2019.4443.
  11. Bjørk M.H., Veiby G., Reiter S.C., Berle J.Ø., Daltveit A.K., Spigset O.et al.: Depression and anxiety in women with epilepsy during pregnancy and after delivery: a prospective population-based cohort study on frequency, risk factors, medication and prognosis. Epilepsia, 2015, 56: 28–39.
  12. Bosak M., Cyranka K., Slowik A.: Hormonal contraception in patients with epilepsy. Ginekol Pol., 2019, 90: 61–65.
  13. Bulau P., Paar W.D., von Unruh G.E.: Pharmacokinetics of oxcarbazepine and 10-hydroxy-carbazepine in the newborn child of an oxcarbazepine treated mother. Eur. J. Clin. Pharmacol., 1988, 34: 311–313.
  14. Centers for Disease Control and Prevention: Breastfeeding report card, 2014. http://www.cdc.gov/breastfeeding/data/reportcard.htm.
  15. Chowdhury R., Sinha B., Sankar M.J., Taneja S., Bhandari N., Rollins N.et al.: Breastfeeding and maternal health outcomes: a systematic review and meta-analysis. Acta Paediatr., Suppl., 2015, 104: 96–113.
  16. Christakis D.A.: Breastfeeding and cognition: can IQ tip the scale?JAMA Pediatr., 2013, 167: 796–797.
  17. Collaborative Group on Hormonal Factors in Breast Cancer: Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96 973 women without the disease. Lancet, 2002, 360: 187–195.
  18. Davanzo R., Dal Bo S., Bua J, Copertino M., Zanelli E., Matarazzo L.: Antiepileptic drugs and breastfeeding. Ital. J. Pediatr., 2013, 9: 50–60.
  19. Diasn C.C, Figueiredo B.: Breastfeeding and depression: A systematic review of the literature. Journal of Affective Disorders, 2015, 171: 142–154.
  20. Drugs and Lactation Database (LactMed), Bethesda: National Library of Medicine, 2006: Updated 2018–2020. www.ncbi.nlm.nih.gov/books/NBK501922/
  21. Dyson L., McCormick F., Renfrew M.J.: Interventions for promoting the initiation of breastfeeding. Cochrane Database Syst. Rev., 2005, CD001688.
  22. Galbally M., Lewis A., van Ijzendoorn M., Permezel M.: The Role of Oxytocin in Mother-Infant Relations: A Systematic Review of Human Studies. Harvard Review of Psychiatry, 2011, 19: 1–14.
  23. Gerard E, Pennell P. Breastfeeding in women with epilepsy in the MONEAD study. Presented at: American Epilepsy Society 2019 Meeting; December 7–10; Baltimore, Maryland. Abstract 1.250. www.aesnet.org/annual_meeting/abstract_search#/
  24. Grosso S., Parisi P., Spalice A., Verrotti A., Balestri P.: Efficacy and safety of lacosamide in infants and young children with refractory focal epilepsy. European Journal of Pediatric Neurology, 2014,18: 55–59.
  25. Hagg S., Spigset O.: Anticonvulsant use during lactation. Drug Saf., 2000, 22: 425–440.
  26. Halani S., Tshering L., Bui E., Clark S.J., Gryndy S.J., Pem T.et al.: Contraception, Pregnancy, and Peripartum Experiences among Women with Epilepsy in Bhutan. Epilepsy Res., 2017, 138: 116–123.
  27. Hale T.W.: Medications and Mothers’ Milk 2019. A Manual of Lactational Pharmacology. 18th ed. Springer Publishing Company, New York 2019, 870.
  28. Hao N., Jiang H., Wu M., Pan T., Yan B., Liu J. et al.: Breastfeeding initiation, duration and exclusivity in mothers with epilepsy from South West China. Epilepsy Res., 2017, 135: 168–175.
  29. Harden C.L., Pennel P.B., Koppel B.S., Hovinga C.A., Gidal B., Meador K.J. et al.: Practice Parameter Update: Management Issues for Women With Epilepsy – Focus on Pregnancy (An Evidence-Based Review): Vitamin K, Folic Acid, Blood Levels, and Breastfeeding: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology, 2009, 73: 142–149.
  30. Hauck F.R., Thompson J., Tanabe K.O., Moon R.Y., Vennemann M.M.: Breastfeeding and Reduced Risk of Sudden Infant Death Syndrome: A Meta-analysis. Pediatrics, 2011, 128: 103–110; DOI:https://doi.org/10.1542/peds.2010-3000.
  31. Horta B.L, de Mola C.L., Victora C.G.: Long-term consequences of breastfeeding on cholesterol, obesity, systolic blood pressure and type 2 diabetes: a systematic review and meta-analysis. Acta Pædiatrica, 2015, 104: 30–37.
  32. Jain A., Concato J., Leventhal J.M.: How good is the evidence linking breastfeeding and intelligence? Pediatrics., 2002, 109: 1044–1053.
  33. Julvez J., Guxens M., Carsin A.E., Forns J., Mendez M., Turner M.C., Sunyer J.: A cohort study on full breastfeeding and child neuropsychological development: the role of maternal social, psychological, and nutritional factors. Dev. Med. Child. Neurol., 2014, 56: 148–156.
  34. Johannessen S.I., Helde G., Brodtkorb E.: Levetiracetam concentrations in serum and in breast milk at birth and during lactation. Epilepsia, 2005, 46: 775–777.
  35. Kon I.Y., Shilina N.M., Gmoshinskaya M.V., Ivanushkina T.A: The Study of Breast Milk IGF-1, Leptin, Ghrelin and Adiponectin Levels as Possible Reasons of High Weight Gain in Breast-Fed Infants. Ann. Nutr. Metab., 2014, 65: 317–323.
  36. Kuhnz W., Koch S., Jacob S., Hartmann A., Helge H., Nau H.: Ethosuximide in epileptic women during pregnancy and lactation period. Placental transfer, serum concentration in nursed infants. Br. J. Clin. Pharmacol., 1984, 18: 671–677.
  37. Kramer G., Hosli I., Glanzmann R., Holzgreve W.: Levetiracetam accumulation in human breast milk. Epilepsia, 2002, 43 (suppl. 7): 105.
  38. Królak-Olejnik B., Błasiak I., Szczygieł A.: Promotion of breastfeeding in Poland: the current situation. Journal of International Medical Research, 2017, 45: 1976–1984.
  39. Lamberti L.M., Fischer Walker C.L., Noiman A., Victora C., Black R.E.: Breastfeeding and the risk for diarrhea morbidity and mortality. BMC Public Health, 2011, 11 (Suppl. 3): S15.
  40. Li R., Dee D., Li C-M., Hoffman H.J., Grummer-Strawn L.M.: Breastfeeding and Risk of Infections at 6 Years. American Academy of Pediatrics, 2014. www.pediatrics.org/cgi/doi/10.1542/peds.2014-0646D
  41. Liporace J., Kao A., D’Abreu A.: Concerns regarding lamotrigine and breastfeeding. Epilepsy Behav., 2004, 5: 102–105.
  42. Lodge C.J., Tan D.J., Lau M.X.Z., Dai X., Tham R., Lowe A.J. et al.: Breastfeeding and asthma and allergies: a systematic review and meta-analysis. Acta Pædiatrica, 2015, 104: 38–53.
  43. Ma L., Shi H., Lian K., Diao Y., Chen Y., Ma C., Kang W.: Highly selective and sensitive determination of several antioxidants in human breast milk using high-performance liquid chromatography based on Ag(III) complex chemiluminescence detection. Food Chem., 2017, 218: 422–426.
  44. Meador K.J., Baker G.A., Browning N., Clayton-Smith J., Combs-Cantrell D.T., Cohen M. et al.: Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N. Eng. J. Med., 2009, 360: 1597–1605.
  45. Meador K.J., Baker G.A., Browning N., Clayton-Smith J., Combs-Cantrell D.T., Cohen M. and NEAD Study Group: Effects of breastfeeding in children of women taking antiepileptic drugs. Neurology, 2010, 75: 1954–1960.
  46. Meador K.J., Baker G.A., Browning N., Cohen M.J., Bromley R.L., Clayton-Smith J. et al.: Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years. JAMA Pediatr., 2014, 168: 729–736.
  47. Miyagi S.J., Collier A.C.: Pediatric development of glucuronidation: the ontogeny of hepatic UGT1A4. Drug Metab. Dispos., 2007, 35: 1587–1592.
  48. Nordmo E., Aronsen L., Waslamd K., Småbrekke L., Vorren S.: Severe apnea in an infant exposed to lamotrigine in breast milk. Ann. Pharmacother., 2009, 43: 1893–1897.
  49. Ohman I., Vitols S., Tomson T.: Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate and during lactation. Epilepsia, 2000, 41: 709–713.
  50. Page-Sharp M., Kristensen J.H., Hacket L.P., Beran R.G., Rampono J., Hale T.W.: Transfer of lamotrigine into breast milk. Ann. Pharmacother., 2006, 40: 1470–1471.
  51. Patelarou E., Girvalaki C., Brokalaki H., Patelarou A., Androulaki Z., Vardavas C.: Current evidence on the associations of breastfeeding, infant formula, and cow’s milk introduction with type 1 diabetes mellitus: a systematic review. Nutrition Reviews, 2012, 70: 509–519.
  52. Pennell P.B.: Use of Antiepileptic Drugs During Pregnancy: Evolving Concepts. Neurotherapeutics, 2016, 13: 811–820.
  53. Peterson A.E., Peŕez-Escamilla R., Labbok M.H., Hight V.von Hertzen H., Van Look P.: Multicenter study of the lactational amenorrhea method (LAM) III: effectiveness, duration, and satisfaction with reduced client-provider contact. Contraception, 2000; 62: 221–230.
  54. Quigley M.A., Hockley C., Carson C., Kelly Y., Renfrew M.J., Sacker A.: Breastfeeding is associated with improved child cognitive development: a population-based cohort study. J. Pediatr., 2012, 160: 25–32.
  55. Reiter S.F., Veiby G., Daltveit A.K., Engelsen B.A., Gilhus N.E.: Psychiatric comorbidity and social aspects in pregnant women with epilepsy – the Norwegian Mother and Child Cohort Study. Epilepsy Behav., 2013, 29: 379–385.
  56. Sankar M.J., Sinha B., Chowdhury R., Bhandari N., Taneja S., Martines J., Bahl R.: Optimal breastfeeding practices and infant and child mortality: a systematic review and meta-analysis. Acta Pædiatrica, 2015, 104: 3–13.
  57. Schaefer Ch.: Antiepileptics. In: Ch.Schaefer, P.Peters, R.K.Miller (eds.) Drugs during Pregnancy and Lactation, 2nd edit., Elsevier2007.
  58. Shi T., Balsells E., Wastnedge E., Singleton R., Rasmussen Z.A., Zar H. J. et al.: Risk factors for respiratory syncytial virus associated with acute lower respiratory infection in children under five years: systematic review and meta-analysis. J. Glob. Health, 2015, 5: 020416. DOI: 10.7189/jogh.05.020416
  59. Shimoyama R., Ohkubo T., Sugawara K., Ogasawara T., Ozaki T., Kagiya A. et al.: Monitoring of phenytoin in human breast milk, maternal plasma and cord blood plasma by solid-phase extraction and liquid chromatography. J. Pharm. Biomed. Anal., 1998, 17: 863–869.
  60. Shimoyama R., Ohkubo T., Sugawara K: Monitoring of carbamazepine and carbamazepine 10,11-epoxide in breast milk and plasma by high performance liquid chromatography. Ann. Clin. Biochem., 2000, 37: 210–215.
  61. Stahl M.M., Neiderud J., Vinge E.: Thrombocytopenic purpura and anemia in a breastfed infant whose mother was treated with valproic acid. J. Paediatr., 1997, 130: 1001–1003.
  62. Sullivan S., Schanler R.L., Kim J.H., Patel A.L.Trawöger R., Kiechl-Kohlendorfer U. et al.: An Exclusively Human Milk-Based Diet Is Associated with a Lower Rate of Necrotizing Enterocolitis than a Diet of Human Milk and BovineMilk-Based Products. J. Pediatr., 2010, 156: 562–567.
  63. Sun Y., Vestergaard M., Christensen J., Olsen J.: Breastfeeding and risk of epilepsy in childhood: a birth cohort study. J. Pediatr., 2011, 158: 924–929.
  64. Taketomo C.K., Hodding J.H., Kraus D.M.: Pediatric and Neonatal Dosage Handbook. 19th edition. Lexicomp Drug Reference Handbooks, 2012.
  65. Tham R., Bowatte G., Dharmage S.C., Tan D.J., Lau M.X.Z., Allen K.J., Lodge C.J.: Breastfeeding and the risk of dental caries: a systematic review and meta-analysis. Acta Pædiatrica, 2015, 104: 62–84.
  66. Tomson T., Palm R., Källén K., Ben-Menachem E., Söderfeldt B., Danielsson B. et al.: Pharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period and lactation. Epilepsia, 2007, 48: 1111–1116.
  67. Turner K., Piazzini A., Franza A., Marconi A.M., Canger R., Canevini M.P.: Epilepsy and postpartum depression. Epilepsia2009, 50 (Suppl. 1): 24–27.
  68. Veiby G., Engelsen B.A., Gilhus NE.: Early child development and exposure to antiepileptic drugs prenatally and through breastfeeding: a prospective cohort study on children of women with epilepsy. JAMA Neurol., 2013, 70: 1367–1374.
  69. Veiby G., Bjork M., Engelsen B.A., Gilhus N.E.: Epilepsy and recommendations for breastfeeding. Seizure, 2015; 28: 57–65.
  70. Verstegen R.H.J., Ito S.: Drugs in lactation. J. Obstet. Gynaecol., 2019, 45: 522–531.
  71. Vohr R., Poindexter B.B., Dusick A.M., McKinley L.T., Wright L.L., and NICHD Neonatal Research Network.: Beneficial Effects of Breast Milk in the Neonatal Intensive Care Unit on the Developmental Outcome of Extremely Low Birth Weight Infants at 18 Months of Age. Pediatrics, 2006, 118: e115–e123; DOI:https://doi.org/10.1542/peds.2005-2382.
  72. Walfisch A., Sermer C., Cressman A., Koren G.: Breast milk and cognitive development: the role of confounders: a systematic review. BMJ Open, 2013, 3: e003259.
  73. Wesson D.R., Camber S., Harkey M., Smith D.E.: Diazepam and desmethyldiazepam in breast milk. J. Psychoactive Drugs, 1985, 17: 55–56.
  74. Wilińska M., Florczyk B., Kościelecka M.: Rola oddziału noworodkowego w popularyzacji naturalnego karmienia – do-świadczenia własne. Postępy Neonatologii, 2005, 2: 46–50.
  75. Wilinska M., Borszewska-Kornacka M.K., Niemiec T., Jakiel G.: Oxidative stress and total antioxidant status in term newborns and their mothers. Ann. Agric. Environ. Med., 2015, 22: 736–740.
  76. World Health Organization.: Global strategy for infant and young child feeding. Geneva, 2001: 1–5.
  77. Zhou J., Shukla V.V., John D., Chen C.: Human Milk Feeding as a Protective Factor for Retinopathy of Prematurity: A Meta-analysis. Pediatrics, 2015, 136: e1576–e1586.
DOI: https://doi.org/10.21307/joepi-2020-005 | Journal eISSN: 2299-9728 | Journal ISSN: 2300-0147
Language: English
Page range: 7 - 25
Submitted on: Jun 17, 2020
Accepted on: Jul 15, 2020
Published on: Jun 22, 2020
Published by: The Foundation of Epileptology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2020 Joanna Jędrzejczak, Maria Wilińska, Ewa Kamińska, Ryszard Lauterbach, Ewa Helwich, Teresa Jackowska, Ewa Nagańska, Natalia Jacyna, Beata Majkowska-Zwolińska, published by The Foundation of Epileptology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.